Charles Albright
Chief Scientific Officer at Editas Medicine
Charles Albright, Ph.D. Chief Scientific Officer Charlie is Chief Scientific Officer of Editas Medicine. He joined Editas Medicine in August 2016 and is responsible for leading the team that is translating the promise of genome editing into a broad class of transformative genomic medicines.
See also: 
Editas Medicine
- Genome editing company.
Details last updated 07-Mar-2020
Charles Albright News
Fixing the genes to cure inherited blindness
Guardian - 04-Mar-2020
Crispr gene editing is a great but a dangerous tool
Read more...
